KORU Medical Systems (NASDAQ:KRMD) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

KORU Medical Systems (NASDAQ:KRMD) released its quarterly earnings results on Wednesday. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02, Zacks reports. The firm had revenue of $8.20 million for the quarter, compared to analyst estimates of $7.49 million. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. During the same period in the previous year, the business earned ($0.05) earnings per share.

KORU Medical Systems Price Performance

NASDAQ:KRMD traded up $0.13 during mid-day trading on Thursday, reaching $2.38. 90,707 shares of the company were exchanged, compared to its average volume of 96,461. The company has a quick ratio of 3.77, a current ratio of 4.55 and a debt-to-equity ratio of 0.02. The stock has a market cap of $108.79 million, a PE ratio of -8.21 and a beta of 0.56. KORU Medical Systems has a 12 month low of $1.98 and a 12 month high of $4.30. The company has a fifty day moving average of $2.19 and a 200 day moving average of $2.24.

Analyst Upgrades and Downgrades

Separately, B. Riley reissued a “buy” rating and issued a $4.00 target price on shares of KORU Medical Systems in a report on Thursday, March 14th.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.